Trades on 1 secondary market

Model Medicines

Model Medicines is an AI-first biotechnology company based in San Diego, California, discovering and developing first-in-class small-molecule drugs by targeting fundamental disease mechanisms it calls biological choke points. Its end-to-end GALILEO AI engine spans drug design, target discovery, and

minimal 10.8 / 100 0 APIs View provider profile →

Company Biotechnology Drug Discovery Artificial Intelligence Pharmaceuticals Small Molecules

Model Medicines is an API provider whose private shares are listed on 1 secondary market: Nasdaq Private Market.

Where It Trades

N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.